About: Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2019 (uk) im März 2019 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q64108954-4FFD1E9D-7667-4F51-AD54-5766534D8087
publication date	2019-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64108954-BDBAB79D-700D-4197-A56F-A2F9D0162683
language of work or name	English
cites work	wds:Q64108954-05BE126F-2973-4437-AE6E-8BE051EBF488 wds:Q64108954-09DEA4B7-995B-4B03-9BE1-ABDED9019691 wds:Q64108954-0D01C278-4F9E-4F32-A412-C02EC84AEFDB wds:Q64108954-1DC3893C-C2FD-47F2-A2E7-2C549BA64590 wds:Q64108954-3926C77C-3880-4A85-B845-339267517CBC wds:Q64108954-3AD579EC-3573-4821-9F07-C7C7632813D2 wds:Q64108954-3B77C90D-B1A3-4988-AE56-28EF3E8CBFBC wds:Q64108954-3BC100E7-32ED-4F94-90D0-0A0B5D5DCAB8 wds:Q64108954-408D46EE-D5E7-40EF-870D-5D44261A0768 wds:Q64108954-421CBA95-8541-4AAD-B72F-5232043797B4 wds:Q64108954-5923EEE9-9705-4909-9FA7-4A68586E11FD wds:Q64108954-5A832D85-A103-460F-965D-11E7718612A1 wds:Q64108954-68694A25-636A-49E3-95BA-6DD30C32D09E wds:Q64108954-771C34B5-1298-48D8-BAC2-5AD4FD46008E wds:Q64108954-8C9FF3D7-7BF0-4257-90B1-5275E7F19F4A wds:Q64108954-8F4AA69E-7F0C-4FC2-9285-AB8581EC6222 wds:Q64108954-8FFD600A-1913-4B17-847C-80B10007C48B wds:Q64108954-950501E0-EECB-4515-A297-C05B6CE919CC wds:Q64108954-A326ACA9-F709-41EB-A5B5-D2711FBA011C wds:Q64108954-AD265BE5-6363-44A0-AEE5-62927DC52D66 wds:Q64108954-CF77E2EB-E96E-4B0A-A309-7F882AEFC127 wds:Q64108954-D1C242E2-60E3-4701-88CE-0C1B0D1E6C98 wds:Q64108954-D3A75029-0FE8-432E-BC76-BB00F51B734B wds:Q64108954-D78C3FB2-B0BE-48A0-9B2B-75D26EFCB575 wds:Q64108954-D8EEE6C0-B83F-4A5B-8410-18AD65473D08 wds:Q64108954-DCC09A1F-79A8-4135-9B2C-35F1FF94EE5F wds:Q64108954-E5E73900-EB7D-475E-9553-ED8B6C066E67 wds:Q64108954-EA8F5CEF-F39E-449F-ADCD-4AE5BF39BC88 wds:Q64108954-F0D87545-D8E7-47EF-A503-2F58E2AA8E25 wds:Q64108954-FA4020B3-0722-4C2D-994D-C995150403D5 wds:Q64108954-FA44EAB4-6C78-491E-8016-3DE9302B2F82
cites work	Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury Severe acute pancreatitis: advances and insights in assessment of severity and management. Treatment of severe acute pancreatitis and its complications Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome. ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients Short and long term outcome of severe acute pancreatitis Cancer invasion and tissue remodeling--cooperation of protease systems and cell types. suPAR: the molecular crystal ball A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor The interaction between urokinase receptor and vitronectin in cell adhesion and signalling uPAR-induced cell adhesion and migration: vitronectin provides the key uPAR: a versatile signalling orchestrator Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis SuPAR and PAI-1 in critically ill, mechanically ventilated patients Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients Clinical evaluation of multiple inflammation biomarkers for diagnosis and prognosis for patients with systemic inflammatory response syndrome Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure. Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU. Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis. suPAR: The unspecific marker for disease presence, severity and prognosis Severe acute pancreatitis: pathogenesis, diagnosis and surgical management Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. [Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome]
author name string	wds:Q64108954-697BE1F1-D3C2-4353-9119-16B25EDCC4A3 wds:Q64108954-7431BBA7-D667-4820-A71F-67F4712576BA wds:Q64108954-92E23B84-B149-47DD-A3FA-1898CD24BAF4 wds:Q64108954-B4335F38-6300-46A3-AC3C-9465C672AAD7 wds:Q64108954-C435A50B-F037-493E-B431-29615B8B5285
author name string	Hui Wang Yujun Wang Li Yu Xiaoling Wu Ding Long
rdfs:label	Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (en) Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (nl)
skos:prefLabel	Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (en) Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (nl)
name	Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (en) Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (nl)
title	wds:Q64108954-359AEFAF-62D3-44F2-AA4F-34E7E40D4CA7
title	Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis (en)
page(s)	wds:Q64108954-1034AEC5-7EEF-47E8-AB53-926E815A31C7
page(s)	335-342
instance of	wds:Q64108954-57C4890F-A915-44A8-ACFC-6533EB556416
instance of	scholarly article
main subject	wds:Q64108954-8565EBBA-EA9A-41D3-A899-BE3E08681271
main subject	placental abruption
PubMed ID	wds:Q64108954-A4CC88E8-A1D1-47A0-9F1C-4C892A41DDEB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30768571
PubMed ID	30768571
published in	wds:Q64108954-B71CE2C8-B7B5-42BF-960F-255265D61055
published in	Pancreas
issue	wds:Q64108954-9E5CA8B3-5D21-404C-A273-788C9DEB7BDB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software